Clinical Trial: A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors

U.S., Nov. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07250386) titled 'A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors' on Sept. 24.

Brief Summary: This study is a single-arm, open-label, dose-escalating + dose-expansion clinical study, aiming to evaluate the safety and efficacy of CEA-targeted CAR-T cell preparations, and to preliminarily observe the study drug in CEA-positive advanced malignant tumors. The pharmacokinetic characteristics of CAR-T cell preparations for the treatment of patients with CEA-positive advanced malignancies were obtained and the recommended dose and infusion schedule.

Study Start Date: Oct. 13

Study Type: INTERVENTIONAL

Condition:...